Id: CBI_1570 | Pages: 325 | Format : PDF | Published : | Author : Amit Sati | Category : Healthcare
Surgical Sutures Market size is estimated to reach over USD 7.82 Billion by 2031 from a value of USD 4.78 Billion in 2023 and is projected to grow by USD 5.00 Billion in 2024, growing at a CAGR of 6.3% from 2024 to 2031.
Surgical sutures are sterile medical threads used to close wounds or surgical incisions, facilitating proper tissue healing. These sutures are available in two main types: absorbable, which dissolves naturally in the body over time, and non-absorbable, which requires removal once the wound has healed. They are made from materials such as silk, catgut, and synthetic polymers like polyglycolic acid and polypropylene, each offering specific advantages based on the type of surgery and healing requirements. The application of surgical sutures spans various fields, including general surgery, cardiovascular, orthopedic, and plastic surgery, where precision and safety are critical. Hospitals, ambulatory surgical centers, and specialized clinics are key end-users of surgical sutures.
The market is driven by the growing number of surgeries being performed globally, primarily due to the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes, along with the rising number of trauma cases. The surge in elective and emergency surgeries, including cardiovascular, orthopedic, and gastrointestinal surgeries, has significantly increased the demand for sutures as a primary wound closure method. Furthermore, the aging population is more prone to chronic illnesses that often require surgical interventions, further boosting the adoption of surgical sutures in both developed and emerging economies. The preference for minimally invasive surgeries often requires sutures with specific characteristics such as absorbability and antimicrobial properties. Thus, as per the market trends analysis, the aforementioned factors add to surgical sutures market growth.
The growing preference for minimally invasive surgical techniques, which often use non-suture closure methods such as staples, adhesives, and sealants, is a key restraint for the surgical sutures market demand. These alternatives provide faster wound closure, reduced scarring, and minimized infection risks compared to traditional sutures, making them popular among both patients and healthcare providers. This shift away from sutures, particularly in laparoscopic and robotic surgeries, has slowed the growth of the suture market in specific areas. Moreover, the adoption of advanced wound care products, such as tissue adhesives, for external wound closure further impacts the usage of traditional sutures, especially in high-tech surgical centers and advanced healthcare facilities.
Technological advancements in suture materials, particularly in the development of synthetic and biodegradable sutures, present significant surgical sutures market opportunities. Biodegradable sutures, which dissolve naturally within the body, are increasingly preferred in both internal and external surgeries due to their reduced risk of infection and the elimination of the need for suture removal. Additionally, antimicrobial-coated sutures are gaining traction as they reduce the risk of post-surgical infections, which is a critical concern for both patients and healthcare providers. Innovations in suture technology, such as drug-eluting sutures that release therapeutic agents to enhance healing, also offer potential for the market. These advanced sutures not only improve patient outcomes but also address the growing need for more effective and safe surgical materials in the healthcare industry.
Based on product type, the market is bifurcated into absorbable sutures and non-absorbable sutures.
The absorbable sutures segment accounted for the largest revenue share of 63.18% in 2023 and is anticipated to register the fastest CAGR during the forecast period.
Based on material, the market is bifurcated into monofilament sutures and multifilament (braided) sutures.
The monofilament sutures segment accounted for the largest revenue of the total surgical sutures market share in 2023.
The multifilament (braided) sutures segment is expected to grow steadily during the forecast period.
Based on application, the market is segmented into cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, ophthalmic surgery, cosmetic & plastic surgery, and others.
The cardiovascular surgery segment accounted for the largest revenue of the overall surgical sutures market share in 2023.
The orthopedic surgery segment is anticipated to register the fastest CAGR during the forecast period.
Based on end-users, the market is segmented into hospitals & clinics, ambulatory surgical centers (ASCs), and specialty clinics.
The hospitals & clinics segment accounted for the largest revenue share in 2023.
The ambulatory surgical centers (ASCs) segment is anticipated to register the fastest CAGR during the forecast period.
The regions covered are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
Asia Pacific region was valued at USD 1.11 Billion in 2023. Moreover, it is projected to grow by USD 1.17 Billion in 2024 and reach over USD 1.95 Billion by 2031. Out of this, China accounted for 32.3% of the total market share. Asia-Pacific is the fastest-growing region in the surgical sutures market, fueled by the rising incidence of chronic diseases, improving healthcare infrastructure, and increasing healthcare investments in countries like China, India, and Japan. The growing number of surgeries, particularly in general surgery, gynecology, and orthopedics, is driving the adoption of sutures. Government initiatives to improve healthcare access and a rising medical tourism industry in countries like India and Thailand further support market development. However, limited access to advanced surgical technologies in rural areas remains a challenge.
North America dominates the market, driven by the high volume of surgical procedures, a well-established healthcare infrastructure, and the prevalence of chronic diseases requiring surgical intervention. The regional trends analysis depicts that The U.S. leads the region due to advancements in minimally invasive surgeries, the adoption of innovative suture materials, and a strong focus on patient safety and wound management. Increasing numbers of cosmetic surgeries and rising healthcare expenditure further boost the market. However, the high costs of advanced sutures and a shift towards surgical staplers may restrain market development.
As per the surgical sutures market analysis, Europe holds a significant share of the market, led by countries like Germany, the UK, and France. The region benefits from a robust healthcare system and an aging population, driving the adoption of surgical interventions, especially in cardiovascular and orthopedic surgeries. Additionally, advancements in suture materials, such as bioabsorbable and antimicrobial sutures, are contributing to market expansion. However, stringent regulatory frameworks and the increasing use of non-invasive surgical techniques could pose challenges to the market's expansion.
The Middle East & Africa region is seeing moderate growth in the market, particularly in Saudi Arabia, the UAE, and South Africa. The market is driven by increasing investments in healthcare infrastructure and the rising demand for surgical interventions, especially in trauma and emergency surgeries. The expansion of medical tourism in the UAE and Saudi Arabia, along with government initiatives to improve healthcare services, boosts the adoption of surgical sutures. However, limited access to advanced suturing materials in some African countries may hamper the market in the region.
The surgical sutures market analysis shows that Latin America is an emerging market, led by Brazil and Mexico. The region's market is driven by the rising number of surgeries related to trauma, cardiovascular diseases, and general surgeries, coupled with an improving healthcare system. Brazil's growing cosmetic surgery market and Mexico's increasing focus on healthcare access are key drivers of the market. However, economic instability and inconsistent healthcare funding in some countries may pose challenges to the market's potential.
The surgical sutures market is highly competitive with major players providing treatments to the national and international markets. Key players are adopting several strategies in research and development (R&D), product innovation, and end-user launches to hold a strong position in the global surgical sutures market. Key players in the surgical sutures industry include -
Product Launches:
Mergers and Acquisitions:
Approvals:
Report Attributes | Report Details |
Study Timeline | 2018-2031 |
Market Size in 2031 | USD 7.82 Billion |
CAGR (2024-2031) | 6.3% |
By Product Type |
|
By Material |
|
By Application |
|
By End-User |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
Surgical sutures market size is estimated to reach over USD 7.82 Billion by 2031 from a value of USD 4.78 Billion in 2023 and is projected to grow by USD 5.00 Billion in 2024, growing at a CAGR of 6.3% from 2024 to 2031.
Segmentation based on product type, material, application, end-user, and region are covered in the report.
Asia Pacific will lead the surgical sutures market.
Major key players in the industry are Ethicon (Johnson & Johnson) (USA), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Smith & Nephew plc (UK), Boston Scientific Corporation (USA), Teleflex Incorporated (USA), DemeTECH Corporation (USA), Internacional Farmacéutica (Mexico), Sutures India Pvt Ltd (India), and Melsungen AG (Germany).